Identification of human annexin A6 as a novel cellular interactant of influenza A M2 protein: implications for influenza life cycle by Ma, HL et al.
POSTER PRESENTATION Open Access
Identification of human annexin A6 as a novel
cellular interactant of influenza A M2 protein:
implications for influenza life cycle
HL Ma
1,2*, F Kien
1, Y Zhang
1,3, J Tse
1, LLM Poon
2, B Nal
1,3
From Institut Pasteur International Network Annual Scientific Meeting
Hong Kong. 22-23 November 2010
Background
During its replication, influenza virus utilizes the host
cellular machineries for many aspects of its life cycle.
Characterization of such virus-host protein-protein
interactions is a must to identify determinants of patho-
genesis. The M2 ion channel protein plays a crucial role
during the entry and late stages of the viral life cycle
where its C-terminal domain, well conserved among
influenza A viruses, is accessible to cellular machineries
after fusion with endosomal membrane and during its
trafficking along the secretory pathway prior to assembly
and budding. The aim of the study is to identify cellular
interactants of M2 that play important regulatory roles
during influenza infection.
Methods
To identify cellular partners of M2 we performed a gen-
ome-wide yeast-two-hybrid (Y2H) screening approach
using the cytosolic domain of M2 as bait and a human
placenta random primed cDNA library as prey and
tested more than 60 million interactions.
Results
From the Y2H screening, an interesting interaction with
the human annexin A6 (ANXA6) protein, a member of
annexin family proteins that binds to phospholipds in a
Ca
2+-dependent manner was identified. Co-immunopre-
cipitation of myc-tagged ANXA6 and viral M2 proteins
co-expressed in HEK293T cells after transfection and
infection confirmed the direct interaction between
ANXA6 and M2. We further investigated whether this
interaction had any functional significance with regards
to influenza life cycle. Using a RNA interference strategy
to silence the ANXA6 gene in human lung epithelial
A549 cells, we observed increased progeny virus titers
either in a single or multiple viral growth kinetics study
suggesting a negative regulatory role for ANAX6 during
viral infection.
Conclusion
A novel interaction between M2 and ANXA6 was iden-
tified. More functional studies are in progress to define
precisely the potential negati v er e g u l a t o r yr o l eo ft h i s
interaction during viral infection. A systematic dissec-
tion of the viral life cycle will be performed to identify
the step(s) affected by the ANXA6 cellular factor using
specific assays such as real-time quantitative RT-PCR in
as i n g l eo rm u l t i p l ev i r a lg r o w t hk i n e t i c ss t u d y ,c e l l
transduction with HA- and M2-pseudotyped lentiviral
particles, virion attachment and internalization assay,
immunofluorescence staining of NP protein as a marker
of viral ribonucleoproteins localization, viral polymerase
activity measurement and viral budding observation by
electron microscopy.
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